# Droxidopa

NDC: 72205-074
Generic name: Droxidopa
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20210219

FDA application: ANDA211741

## Active ingredients

- DROXIDOPA: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-074"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-074
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d